H.R. 2430 · 115th Congress
FDA Reauthorization Act of 2017
- Stage
- Signed by the president
- Sponsor
- Greg Walden
- Introduced
- 2017-05-16
- Latest action
- 2017-08-18 · Signed by President.
Action history
- 2017-08-18Signed by President.
- 2017-08-07Presented to President.
- 2017-08-03Motion to proceed to measure considered in Senate.
- 2017-08-03Cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 96 - 1. Record Vote Number: 185.
- 2017-08-03Motion to proceed to consideration of measure agreed to in Senate by Unanimous Consent.
- 2017-08-03Measure laid before Senate by motion.
- 2017-08-03Passed Senate without amendment by Yea-Nay Vote. 94 - 1. Record Vote Number: 187.
- 2017-08-03Message on Senate action sent to the House.
- 2017-08-01Motion to proceed to consideration of measure made in Senate.
- 2017-08-01Cloture motion on the motion to proceed to the measure presented in Senate.
- 2017-07-17Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.
- 2017-07-13Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
- 2017-07-12Motion to reconsider laid on the table Agreed to without objection.
- 2017-07-12On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
- 2017-07-12DEBATE - The House proceeded with forty minutes of debate on H.R. 2430.
- 2017-07-12Considered under suspension of the rules.
- 2017-07-12Mr. Walden moved to suspend the rules and pass the bill, as amended.
- 2017-07-11Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-201.
- 2017-07-11Placed on the Union Calendar, Calendar No. 138.
- 2017-06-07Committee Consideration and Mark-up Session Held.
- 2017-06-07Ordered to be Reported (Amended) by the Yeas and Nays: 54 - 0.
- 2017-05-18Subcommittee Consideration and Mark-up Session Held.
- 2017-05-18Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
- 2017-05-16Introduced in House
- 2017-05-16Referred to the House Committee on Energy and Commerce.